Maravai LifeSciences
MRVI
MRVI
149 hedge funds and large institutions have $312M invested in Maravai LifeSciences in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 59 increasing their positions, 42 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
149
Holders Change
-35
Holders Change %
-19.02%
% of All Funds
2%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
59
Reduced
42
Closed
52
Calls
$1.85M
Puts
$133K
Net Calls
+$1.72M
Net Calls Change
+$1.38M
Top Buyers
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.49M |
| 2 |
Millennium Management
New York
|
-$2.72M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.02M |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$1.46M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.21M |
